Cardiac resynchronization therapy: past, present, and future

Area of Science:

• Cardiology
• Medical Devices
• Heart Failure Management

Background:

• Cardiac resynchronization therapy (CRT), also known as biventricular pacing, is a standard treatment for symptomatic heart failure (HF).
• CRT is indicated for patients with reduced left ventricular (LV) function and significant electrical dyssynchrony.
• Despite its benefits, a notable portion of patients do not respond to CRT, highlighting a need for further research and optimization strategies.

Purpose of the Study:

• To review the electrical and physiological basis of biventricular pacing.
• To summarize key clinical trials evaluating CRT efficacy.
• To discuss methods for enhancing patient response to CRT and outline future challenges.

Main Methods:

• Literature review of landmark clinical trials and physiological studies.
• Analysis of strategies for optimizing CRT response.
• Discussion of future directions in CRT delivery and patient care.

Main Results:

• CRT has demonstrated significant improvements in morbidity and mortality in selected HF populations.
• Understanding the electrical and physiological rationale is crucial for effective CRT implementation.
• Various strategies exist to optimize CRT response, though nonresponse remains a clinical challenge.

Conclusions:

• CRT is an established therapy for specific heart failure patients, improving clinical outcomes.
• Optimizing CRT response requires a multifaceted approach, addressing patient selection, device programming, and lead placement.
• Future research should focus on improving CRT delivery, patient selection, and long-term management to maximize benefits and minimize nonresponse.